0001923102-22-000001.txt : 20220412 0001923102-22-000001.hdr.sgml : 20220412 20220412151017 ACCESSION NUMBER: 0001923102-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220412 DATE AS OF CHANGE: 20220412 EFFECTIVENESS DATE: 20220412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Drusolv Therapeutics, Inc. CENTRAL INDEX KEY: 0001923102 IRS NUMBER: 822704169 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-441520 FILM NUMBER: 22822052 BUSINESS ADDRESS: STREET 1: 1425 LOCUST STREET STREET 2: UNIT 7C CITY: PHILADELPHIA STATE: PA ZIP: 19102 BUSINESS PHONE: 404-536-4012 MAIL ADDRESS: STREET 1: 1425 LOCUST STREET STREET 2: UNIT 7C CITY: PHILADELPHIA STATE: PA ZIP: 19102 D 1 primary_doc.xml X0708 D LIVE 0001923102 Drusolv Therapeutics, Inc. 1425 LOCUST STREET UNIT 7C PHILADELPHIA PA PENNSYLVANIA 19102 404-536-4012 PENNSYLVANIA None None Corporation true 2017 John G. Edwards 1425 Locust Street Unit 7C Philadelphia PA PENNSYLVANIA 19102 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2022-03-31 false true true true Convertible Notes. The notes are convertible into Common or Preferred Stock of the Company. false 0 2000000 500000 1500000 false 1 0 0 120000 true false Drusolv Therapeutics, Inc. John G. Edwards John G. Edwards Chief Executive Officer 2022-04-12